| Mariano Olmo Lopez, MD | |
|
Bf1 Calle 22, Villa Universitaria, Humacao, PR 00791-4339 | |
| (787) 217-4858 | |
| Not Available |
| Full Name | Mariano Olmo Lopez |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | Bf1 Calle 22, Humacao, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295132124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 18950 (Puerto Rico) | Primary |
| Entity Name | Neomed Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790776334 PECOS PAC ID: 1850284100 Enrollment ID: O20040414001654 |
News Archive
A new study conducted on laboratory animals shows that exposure to cannabis and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear.
University College Dublin (UCD) is leading SOPHIA (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), a new €16 million EU and industry supported international research consortium launched today.
Obesity is associated with a 25 percent increase in the risk of developing mood and anxiety disorders and a 25 percent decrease in likeliness for substance abuse.
Takeda Pharmaceuticals North America, Inc. announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than esomeprazole.
Médecins Sans Frontières/Doctors without Borders (MSF) have announced that three trials of Ebola therapies will begin in West Africa this December.
› Verified 4 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
A new study conducted on laboratory animals shows that exposure to cannabis and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear.
University College Dublin (UCD) is leading SOPHIA (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), a new €16 million EU and industry supported international research consortium launched today.
Obesity is associated with a 25 percent increase in the risk of developing mood and anxiety disorders and a 25 percent decrease in likeliness for substance abuse.
Takeda Pharmaceuticals North America, Inc. announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than esomeprazole.
Médecins Sans Frontières/Doctors without Borders (MSF) have announced that three trials of Ebola therapies will begin in West Africa this December.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mariano Olmo Lopez, MD Bf1 Calle 22, Villa Universitaria, Humacao, PR 00791-4339 Ph: (787) 217-4858 | Mariano Olmo Lopez, MD Bf1 Calle 22, Villa Universitaria, Humacao, PR 00791-4339 Ph: (787) 217-4858 |
News Archive
A new study conducted on laboratory animals shows that exposure to cannabis and stress during adolescence may lead to long-term anxiety disorders characterized by the presence of pathological fear.
University College Dublin (UCD) is leading SOPHIA (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), a new €16 million EU and industry supported international research consortium launched today.
Obesity is associated with a 25 percent increase in the risk of developing mood and anxiety disorders and a 25 percent decrease in likeliness for substance abuse.
Takeda Pharmaceuticals North America, Inc. announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than esomeprazole.
Médecins Sans Frontières/Doctors without Borders (MSF) have announced that three trials of Ebola therapies will begin in West Africa this December.
› Verified 4 days ago
Dr. Juan R. Ortiz Guevara, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: Font Martelo 358 Suite 204, Humacao, PR 00791 Phone: 787-852-3929 Fax: 787-852-3910 | |
Roberto Velez De Jesus, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Carr #3 Km 85.6 Candelero Arriba, Edificio Plaza Del Mar, Humacao, PR 00791 Phone: 787-850-6654 | |
Dr. Annette Del Toro, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 60 Ave Munoz Marin, Humacao, PR 00791 Phone: 787-850-4655 Fax: 787-850-3800 | |
Diana Delgado, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Hospital Ryder, Humacao, PR 00792 Phone: 787-852-0768 Fax: 787-852-8248 | |
Harry Lopez Rodriguez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Carretera 924 Km 2. 7, Bo Pitahaya, Humacao, PR 00791 Phone: 787-852-4743 Fax: 787-852-5292 | |
Howard Alan Smith, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 355 Font Martelo Ave., Humacao, PR 00792 Phone: 787-852-0768 |